PxROAR & CureROAR

AVAC's PxROAR and CureROAR programs train US, European and African partners in HIV cure and prevention research and implementation advocacy. The program provides mentorship, peer support, networking opportunities,technical support and financial assistance.

Meet the members of PxROAR US, PxROAR Europe, PxROAR Africa, PxROAR Transgender and CureROAR.

The ROAR programs have two goals: to educate its members on both the science of HIV prevention and cure research and on the implementation process, and to provide a platform for specific advocacy campaigns. The five cadres of PxROAR advocates are based in Africa, the US and Europe, and represent the range of HIV-affected communities.

CureROAR: The HIV cure field is undergoing a period of robust scientific investigation. The CureROAR program supports members to understand the relevant science and prepare an advocacy agenda that will ensure cure research reflects the needs, priorities and experiences of all populations affected by HIV. CureROAR is made up of members from countries where cure research is taking place and CureROAR members represent communities affected by HIV.

PxROAR TG: PxROAR TG articulates an HIV prevention advocacy agenda specifically for trans people within the framework of key populations’ needs and programs. Members are based in Southern and Eastern Africa.

PxROAR Africa: Through dialogues, shared learning and strategic action, this ROAR team advances the human right to health, including comprehensive HIV prevention treatment and care. With extensive experience in advocacy and activism aimed at securing self-determination, free expression, and culturally competent health services, PxROAR AFRICA’s work focuses on agendas that will eventually end HIV epidemics in their communities. Members represent LGBTQI individuals, sex workers and other criminalized and marginalized populations.

In Europe and the US, the PxROAR program also seeks to expand members’ capacity to contribute to advocacy for research, development and implementation of new HIV prevention options. Members track FDA and EMA licensing processes and advocate for sustained funding to key research entities including the US National Institutes of Health and European-based research institutes funded through the EU’s Financial Framework 2014-2020 and Horizon 2020.

For more information on the PxROAR program, please email avac@avac.org.